comparemela.com

Pounce Arterial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023,.

New yorkUnited statesEden prairieGary maharajSurmodics incAbbott vascular incQuarter fiscalRecent businessEndovascular issuesLow profileThrombectomy systemMedical deviceVitro diagnosticsAbbott vascularCall todayPrivate securities litigation reform act

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Fina

EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023, and updated its financial guidance for fiscal year ending Septemb.

New yorkUnited statesEden prairieGary maharajAbbott vascular incSurmodics incQuarter fiscalRecent businessEndovascular issuesLow profileThrombectomy systemMedical deviceVitro diagnosticsAbbott vascularCall todayPrivate securities litigation reform act

Surmodics, Inc (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript

Operator: Welcome everyone to Surmodics Fourth Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.

New yorkUnited statesTim arensGary maharajPerformance coating servicesSurmodics incCall transcript novemberSurmodics fourth quarterFiscal yearInvestor relationsPrivate securities litigation reform actSurmodic presidentChief executiveMedical devicePerformance coatingsPounce arterial thrombectomy

Surmodics, Inc (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript

Operator: Welcome everyone to Surmodics’ Second Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast.

Mike matsonGary maharajTim arensTimothy arensSurmodics incPeripheral intervention communityCall transcript aprilSurmodic second quarterFiscal yearInvestor relationsSafe harbor provisionsPrivate securities litigation reform actSurmodics presidentChief executiveSurveil drug coated balloonSublime radial

Surmodics, Inc (SRDX) CEO Gary Maharaj on Q2 2022 Results - Earnings Call Transcript

Surmodics, Inc. (NASDAQ:NASDAQ:SRDX) Q2 2022 Earnings Conference Call April 27, 2022, 08:30 AM ET Company Participants Tim Arens - SVP, Finance & CFO Gary Maharaj - President & CEO.

United statesBaton rougeSouth dakotaCity ofUnited kingdomCharing crossDavid saxonGary anselJim sidotiMike petuskyGary maharajTim arensCompany participantsSurmodics incPhysician steering committeeCharing cross international symposium

vimarsana © 2020. All Rights Reserved.